Výsledky vyhledávání - "A. Prada Ojeda"

Akademický článek

Utilidad de los fármacos modificadores de enfermedad (FAME) en el tratamiento de las espondiloartropatías

Autor: Prada Ojeda, Alejandro, Otón Sánchez, Teresa, Sanz Sanz, Jesús

Publikováno v: In Seminarios de la Fundacion Espanola de Reumatologia 2010 11(3):107-114

POS1170 ASYMPTOMATIC URATE-CRYSTALS DEPOSITS IN PATIENTS WITH STAGES 3-5 CHRONIC KIDNEY DISEASE DETECTED BY ULTRASOUND

Autor: E. Calvo-Aranda, L. Barrio Nogal, B. A. Blanco Cáceres, M. Novella-Navarro, D. Peiteado, J. Arroyo Palomo, E. De Miguel, A. Prada Ojeda, L. Sala Icardo, M. T. Navio Marco, M. Vázquez Díaz, C. M. Gomez-Gonzalez, R. Alcazar Arroyo, J. A. Martin Navarro, M. Vaga Gallardo, M. Fernandez Lucas, M. E. Diaz Dominguez

Publikováno v: Annals of the Rheumatic Diseases. 81:913.2-913

BackgroundOne in ten patients with hyperuricemia may develop gout over time, with urate deposition sometimes asymptomatic. Recent reviews support ultrasound (US) to assess asymptomatic hyperuricemic (AH) patients to detect gout lesions, showing doubl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f199a2ad5b5aa49d46178ec7e36d4bba
https://doi.org/10.1136/annrheumdis-2022-eular.4045

Zobrazit plný text záznamu

POS0783 ASSOCIATION BETWEEN ENVIRONMENTAL FACTORS AND SALIVARY GLAND ULTRASOUND FINDINGS IN PATIENTS WITH SUSPECTED PRIMARY SJÖGREN SYNDROME

Autor: L. Barrio Nogal, M. Novella-Navarro, L. Sala-Icardo, A. Prada-Ojeda, C. Bohórquez, A. Pérez Gómez

Publikováno v: Annals of the Rheumatic Diseases. 81:678.2-679

BackgroundThe influence of environmental factors in primary Sjögren’s syndrome (pSS) and their relationship with serological, histological and ultrasound findings remains still poorly understood. A possible protective effect of female sex hormones

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bffab8c5e92bd2e88cde9d6ea5d6edb8
https://doi.org/10.1136/annrheumdis-2022-eular.4814

Zobrazit plný text záznamu

Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland

Autor: Fernando Pérez Ruiz, Neus Quilis, Eliseo Pascual, Boris Anthony Blanco Cáceres, Mariano Andrés, Francisca Sivera, Paloma Vela, Enrique Calvo-Aranda, Cesar Diaz-Torne, Alejandro Prada-Ojeda

Publikováno v: ANNALS OF THE RHEUMATIC DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Dear Editor, We read with interest the recent article by Singh and Cleveland on the hypersensitivity risk of allopurinol (ALP) and febuxostat (FBX) compared with colchicine.1 A common challenge when using ALP, linked to hypersensitivity reactions, is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e1cfdfe7f807f4b224ecb4dc919e56b
https://pubmed.ncbi.nlm.nih.gov/32616606

Zobrazit plný text záznamu

A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3

Autor: Alejandro Prada-Ojeda, Maria Carmen Ortega de la O, José Luis Cabrera-Alarcón, Paloma García de la Peña Lefebvre, Iustina Janta, M. Novella-Navarro, Francisco Aramburu-Muñoz, Cesar Diaz-Torne, Enrique Calvo-Aranda, Ana Urruticoechea-Arana, Luis Sala-Icardo

Publikováno v: RHEUMATOLOGY INTERNATIONAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

The aim of this study was to assess changes in the estimated glomerular filtration rate (eGFR) in gouty patients with chronic kidney disease (CKD) using a "treat-to-target" (T2T) approach in gout. This multicenter observational retrospective study in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc885de9ed10a46b4b285d298a405ec0
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1829

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SAT0439 RENOPROTECTIVE EFFECT OF URATE LOWERING THERAPY IN GOUTY PATIENTS WITH MODERATE CHRONIC KIDNEY DISEASE

Autor: Paloma García de la Peña, José Luis Cabrera-Alarcón, Enrique Calvo-Aranda, M. Novella-Navarro, Iustina Janta, Francisco Aramburu-Muñoz, Luis Sala-Icardo, Alejandro Prada-Ojeda

Publikováno v: Saturday, 15 June 2019.

Background Approximately 25% of gouty patients suffer from chronic kidney disease (CKD). High serum uric acid (sUA) levels have been related to estimated glomerular filtration-rate (eGFR) imbalance. Beneficial effect of treatment with xanthine oxidas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a4d003a42ff5f6d2471650ff6d046e0
https://doi.org/10.1136/annrheumdis-2019-eular.2362

Zobrazit plný text záznamu

SAT0441 SKIN ADVERSE EVENTS WITH FEBUXOSTAT IN GOUT PATIENTSWITH PREVIOUS SKIN REACTIONS TO ALLOPURINOL. A MULTICENTRE DESCRIPTIVE STUDY

Autor: P. Vela-Casasempere, Cesar Diaz Torne, Mariano Andrés, Francisca Sivera, Enrique Calvo-Aranda, Boris Anthony Blanco Cáceres, Alejandro Prada-Ojeda, Fernando Perez-Ruiz, Eliseo Pascual, Neus Quilis Marti

Publikováno v: Saturday, 15 June 2019.

Background: Allopurinol is first-line urate-lowering drug (ULD) for patients with gout. However, around 10% of them refer adverse events, often at skin, which can be severe. Febuxostat is a non-purine selective xanthine oxidase inhibitor, often a the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cf524ff898d82a122befc563cbcf344a
https://doi.org/10.1136/annrheumdis-2019-eular.4394

Zobrazit plný text záznamu

SAT0314 IMPLEMENTATION OF AN ASSESSMENT CHECKLIST FOR PATIENTS WITH SPONDYLOARTHRITIS IN DAILY PRACTICE

Autor: Estíbaliz Loza, Laura Cebrian, Victoria Navarro-Compán, Elena Rabadán, Sheila Melchor, Álvaro García Martos, Mª Teresa Navio, Laura Zamudio González, L. Lojo, Virginia Villaverde, Esther Rodríguez Almaraz, B. Joven-Ibáñez, Almodovar Raquel, Pedro Zarco-Montejo, Alejandro Prada-Ojeda

Publikováno v: Saturday, 15 June 2019.

Background Nowadays, despite international and national guidelines on the evaluation and management of spondyloarthritis (SpA), several studies have depicted a sub-optimal assessment of these diseases. Objectives To analyze the feasibility and change

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a723e56c50fe476042a685e89755a8fb
https://doi.org/10.1136/annrheumdis-2019-eular.3093

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání